PLN-101095
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLN-101095, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors [Phase 1]